Clinical trial

Can Methylprednisoloneacetate Prevent Seroma After Mastectomy for Primary Breast Cancer

NCT01380912

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2010-08-01

PhaseN/A

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2011-06-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

methylprednisoloneacetateDRUG

Sponsors & collaborators

Copenhagen University Hospital at Herlevlead sponsor

University Hospital, Gentofte, Copenhagencollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01380912 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.